Van Hulzen Asset Management LLC bought a new position in Addus HomeCare Corporation (NASDAQ:ADUS – Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The firm bought 12,041 shares of the company’s stock, valued at approximately $1,210,000.
A number of other large investors have also recently modified their holdings of the stock. Oregon Public Employees Retirement Fund raised its stake in Addus HomeCare by 2.5% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 4,153 shares of the company’s stock worth $446,000 after buying an additional 103 shares in the last quarter. ProShare Advisors LLC lifted its holdings in Addus HomeCare by 3.1% in the fourth quarter. ProShare Advisors LLC now owns 3,527 shares of the company’s stock worth $379,000 after buying an additional 105 shares during the period. CANADA LIFE ASSURANCE Co boosted its position in Addus HomeCare by 0.6% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company’s stock valued at $2,150,000 after acquiring an additional 106 shares in the last quarter. State of Wyoming boosted its position in Addus HomeCare by 25.7% during the 4th quarter. State of Wyoming now owns 523 shares of the company’s stock valued at $56,000 after acquiring an additional 107 shares in the last quarter. Finally, Pathstone Holdings LLC grew its holdings in shares of Addus HomeCare by 0.9% during the 3rd quarter. Pathstone Holdings LLC now owns 12,727 shares of the company’s stock worth $1,502,000 after acquiring an additional 112 shares during the period. Institutional investors own 95.35% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on ADUS shares. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Royal Bank Of Canada upped their price target on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Barclays increased their price objective on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a report on Wednesday, July 8th. Citizens Jmp restated a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a report on Monday, May 18th. Finally, Weiss Ratings upgraded shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $130.88.
Addus HomeCare Trading Up 0.0%
NASDAQ ADUS opened at $120.82 on Tuesday. Addus HomeCare Corporation has a 12 month low of $87.95 and a 12 month high of $124.43. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05. The stock’s fifty day moving average price is $109.99 and its 200-day moving average price is $102.58. The stock has a market cap of $2.26 billion, a P/E ratio of 21.20, a P/E/G ratio of 1.62 and a beta of 0.87.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last posted its quarterly earnings results on Monday, August 3rd. The company reported $1.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.70 by $0.03. The firm had revenue of $377.41 million during the quarter, compared to analyst estimates of $376.24 million. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.Addus HomeCare’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.49 EPS. As a group, equities analysts forecast that Addus HomeCare Corporation will post 6.29 EPS for the current fiscal year.
Insiders Place Their Bets
In other Addus HomeCare news, insider Heather Brianne Dixon sold 288 shares of the firm’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the sale, the insider directly owned 44,371 shares in the company, valued at approximately $4,160,668.67. This trade represents a 0.64% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 4.10% of the company’s stock.
About Addus HomeCare
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Featured Stories
- Five stocks we like better than Addus HomeCare
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
